Cutting-edge data analytics from pipeline to market

Book a Free Consultation

Real-time, actionable insights powered by AI

Innoplexus provides advanced artificial intelligence (AI) and blockchain solutions that support all stages of drug development from pipeline to market. Innoplexus identifies and extracts structured and unstructured life science data by scanning up to 95% of the world wide web and merges it with enterprise and third-party data in an ongoing, real-time process. This continually updated data repository is the foundation of our custom and off-the-shelf solutions that serve pharmaceutical companies, the biotech industry, and contract research organizations.

Our strengths are focused on faster drug discovery

Proprietary Technologies

Our leading proprietary AI technology for life sciences generates real-time insights and relevant results for better decision-making

Self-Learning Ontology

Our self-learning ontology understands the language of life sciences and enables context-based searches across multiple data sources

Life Science Data Ocean

Our technology connects trillions of data points from structured, unstructured, public, third-party, corporate, and unpublished data

Ontosight® – Accelerate the drug development process

Ontosight® offers the largest searchable library of life sciences information to help companies develop accurate therapies much faster, saving them time and costs. The platform applies proprietary AI technologies along with our life sciences ontology to crawl, aggregate, analyze, and visualize life sciences data from multiple published, unpublished, third-party, and enterprise sources.

This one stop solution for life sciences comes with various modules and dashboards to help you optimize work potential with the most relevant knowledge, real-time intelligence, and discovery of new patterns across pre-clinical, clinical, regulatory, and commercial phases of drug development.

Accelerate your Success with Ontosight®

Ontosight® Discover

An innovative and intuitive semantic discovery engine that understands biomedical concepts and allows users to see relevant results in context across multiple data sources

Learn More

Ontosight® Explore

A life sciences–specific search engine that enables exploration, identification, and building of various direct and indirect connections between biological entities such as drugs, targets, pathways, and diseases

Learn More

Ontosight® Influence

Real-time discovery, management, and network analysis of top and emerging key opinion leaders (KOLs) across the entire drug discovery and development value chain

Learn More

Ontosight® Integrate

A 100% automated, self-service engine that leverages internal and external data for real-time analysis of products/sales performance and status of budget and expenses

Learn More

Our Technology is domain-agnostic.
We empower:

Pharma

CROs

Biotech

Academic Research

Pharmaceutical Investment

What our clients say

“Real Partnership”

Data analytics is becoming a core competency for Pharma. We do not want to outsource this anymore! I love the fact that you are focused on empowering our analytics teams with your solutions. This is a clear differentiation versus all the competitors. You seem to be working on a true partnership model.
C-Suite, one of the world’s largest Pharma companies

“Efficiency and quality“

Innoplexus using their AI technology delivered what we required on time with great quality. The resilience and expertise made us choose Innoplexus again
Business Unit Head, top pharma company

“Problem solvers“

“Meet the finish line” effort of Innoplexus helped us make our decision easier for choosing a problem solver. We look forward to work with them more and more.
Director, Medical Affairs, top pharma company

“Cutting edge tech!“

Innoplexus has cutting edge technology which could potentially revolutionize Pharmaceutical industry…. I am excited to be working with them.
Director, Medical Affairs, top pharma company

“Great technology and data”

Having sufficient data and analytical capability is critical to being able to identify potential baseline biomarkers. In working with Innoplexus our expectation was to leverage its technology to pool all of the publicly available patient level data that might help us in delivering on this objective. The Innoplexus team was very fast to develop its strategy to address our request.
E. Hughes, Novartis AG

Featured In

Latest Media & Blogs

Download Technology Capabilities